Publication
Generative AI: A global guide to key IP considerations
Artificial intelligence (AI) raises many intellectual property (IP) issues.
United States | Publication | December 28, 2021
The US Supreme Court has scheduled one hour for oral arguments on January 7 to address OSHA's COVID "vaccine or test" Emergency Temporary Standard (ETS). The Court will also hear arguments challenging the earlier Centers for Medicare & Medicaid Services' vaccination requirement for healthcare workers.
Multiple procedural and substantive/Constitutional challenges to the ETS have been filed by states' Attorneys General, trade associations, employers, labor unions and others. At the current stage, the Supreme Court could reinstitute a stay on enforcement of the ETS by OSHA pending further legal proceedings or could allow OSHA to proceed.
The Supreme Court is considering challenges to the Sixth Circuit Court of Appeals December 17 decision dissolving an earlier stay implemented by the Fifth Circuit. The Sixth Circuit was assigned by random lottery to consider all legal challenges to the ETS filed in the various circuit courts. In dissolving the stay, the majority, in a 2-1 decision, determined that OSHA was likely to prevail on the challenges. No final rulings on any have been issued.
If permitted to stand, the ETS requires employers with 100-plus employees to either develop and enforce a mandatory COVID vaccination policy or provide workers with the choice to get vaccinated or undergo weekly testing.
Publication
Artificial intelligence (AI) raises many intellectual property (IP) issues.
Publication
On 21 November 2023 and following extensive consultation periods, the amendment to the Climate Delegated Act (Delegated Regulation (EU) 2021/2139 of 4 June 2021) (the Climate Delegated Act) was formally adopted by the European Commission and published in the EU Official Journal (Delegated Regulation (EU) 2023/2485 of 27 June 2023) (the Climate Delegated Act Amendment).
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023